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Background For the same body mass index (BMI) level, waist circumference (WC) is higher in
more recent years. How this impacts diabetes and prediabetes prevalence in the United States
and for different race/ethnic groups is unknown. We examined prevalence differences in diabe-
tes and prediabetes by BMI over time, investigated whether estimates were attenuated after
adjusting for waist circumference, and evaluated implications of these patterns on race/ethnic
disparities in glycemic outcomes.
Methods Data came from 12 614 participants aged 20 to 74 years from the National Health
and Nutrition Examination Surveys (1988‐1994 and 2007‐2012). We estimated prevalence dif-
ferences in diabetes and prediabetes by BMI over time in multivariable models. Relevant interac-
tions evaluated race/ethnic differences.
Results Among normal, overweight, and class I obese individuals, there were no significant
differences in diabetes prevalence over time. However, among individuals with class II/III obesity,
diabetes prevalence rose 7.6 percentage points in 2007‐2012 vs 1988‐1994. This estimate was
partly attenuated after adjustment for mean waist circumference but not mean BMI. For predia-
betes, prevalence was 10 to 13 percentage points higher over time at lower BMI values, with min-
imal attenuation after adjustment for WC. All patterns held within race/ethnic groups. Diabetes
disparities among blacks and Mexican Americans relative to whites remained in both periods,
regardless of BMI, and persisted after adjustment for WC.
Conclusions Diabetes prevalence rose over time among individuals with class II/III obesity
and may be partly due to increasing waist circumference. Anthropometric measures did not
appear to account for temporal increases in prediabetes, nor did they attenuate race/ethnic dis-
parities in diabetes. Reasons underlying these trends require further investigation.
KEYWORDS
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The prevalence of adult obesity remains high in the United States,
but recent reports suggest that it may be leveling off.1 Despite this
plateau, waist circumference (WC) has increased over a similar
timeframe to a greater extent than what would be expected given
changes in body mass index (BMI).2–6 Moreover, at the same BMI
level, WC is higher in more recent years particularly at the upper
end of the BMI distribution.3,6 This pattern extends across race/eth-
nic groups but is especially predominant in Mexican Americans and
non‐Hispanic whites.6 These findings suggest that body shape maybe changing even when obesity as determined by BMI has
plateaued.
One potential consequence of this pattern may be a concomitant
rise in diabetes and prediabetes for the same BMI level, especially
across parts of the BMI distribution where WC has been increasing
over time. Recent reports have drawn attention to the alarming rise
in diabetes and prediabetes in the United States, much of which has
been attributable to the obesity epidemic.7–9 However, it is unknown
if diabetes and prediabetes have also been increasing at the same
BMI level, if dysglycemia is higher over time only at certain parts of
the BMI distribution, and if this pattern may be attributable to temporal
increases in WC. Evaluating whether increasing WC, independent of
BMI, plays a role in diabetes and prediabetes trends can improve our
understanding of the reasons underlying the growing diabetes
epidemic in the United States.
Although dysglycemia has been shown to affect all segments of
the US population, non‐Hispanic blacks and Mexican Americans bear
a disproportionate burden, independent of BMI.10,11 There is also
evidence that diabetes in minorities has increased over time at a faster
rate than among whites and is not explained by BMI alone.12,13
Increases in WC adjusted for BMI have not disproportionately affected
blacks and Mexican Americans relative to whites.6 Nevertheless, it is
possible that minorities may be more sensitive to adverse changes in
body composition given their higher prevalence of diabetes compared
to whites regardless of anthropometry. This may result in even larger
race/ethnic disparities in dysglycemia over time even for the same
BMI level.
Using data from nationally representative health surveys spanning
over a 20‐year period, we examined trends in diabetes and prediabetes
by BMI over time, whether these patterns were present across all race/
ethnic groups, and we evaluated the implications of these trends on
race/ethnic disparities in glycemic outcomes. We also investigated
whether the observed patterns remained after accounting for temporal
increases in WC.2 | MATERIALS AND METHODS
2.1 | Data
Data came from the National Health and Nutrition Examination
Surveys (NHANES), a series of ongoing national surveys conducted
by the National Center for Health Statistics.14 NHANES uses a
complex, multistage sample design and is intended to be nationally
representative of the US noninstitutionalized population. Survey
participants completed in‐home interviews followed by medical
and laboratory examinations in mobile examination centers. Addi-
tionally, half of those who participate in the medical examination
were asked to fast overnight for laboratory testing, comprising a
nationally representative fasting subsample. These analyses were
restricted to this subsample. We used data from NHANES III
(1988‐1994) and the continuous NHANES 2007‐2012 and included
nonpregnant adults aged 20 to 74 years. We excluded participants
with incomplete anthropometry data, as well as participants who
were underweight (BMI <18.5 kg/m2; n = 213), yielding a sample
size of 12 614 across the 2 periods (NHANES III: n = 6443;
2007‐2012: n = 6171). The National Center for Health Statistics
ethics review board reviewed and approved the surveys, and partic-
ipants gave informed consent.2.2 | Definition of diabetes and prediabetes
Participants were classified as having diabetes if they met any of the
following criteria: (1) During the in‐home interview, they answered
yes to the question of whether, outside of pregnancy, a doctor or
other health care professional had ever told them they had diabetes;
or they reported taking insulin or diabetes medicines; (2) laboratoryresults indicated diabetes by either a fasting plasma glucose (FPG)
value ≥126 mg/dL or a glycated hemoglobin (HbA1c) ≥6.5%
(48 mmol/mol).15 We defined prediabetes as having HbA1c in the
range of 5.7% to <6.5% (39 to <48 mmol/mol) or FPG 100 to
<126 mg/dL. Fasting plasma glucose was measured using the same
hexokinase enzymatic method in NHANES III and as in the continu-
ous surveys. Hemoglobin A1c was measured using whole blood at a
central laboratory by a high‐performance liquid chromatographic
assay and standardized according to the method of the Diabetes
Control and Complications Trial.162.3 | Anthropometric and demographic measures
Trained personnel used a standardized protocol to collect anthro-
pometric measurements. Height was measured in centimeters while
the participant stood without shoes, and weight was measured in
kilograms while the participant stood without shoes and in light
clothing. BMI was calculated as weight (kg) per height (m2). BMI
was used to classify participants as normal weight (18.5‐24.9),
overweight (25.0‐29.9), class I obesity (30.0‐34.9), and class II/III
obesity (≥35.0 kg/m2). WC was measured in centimeters at the
midpoint between the bottom of the ribs and the top of the iliac
crest. Demographic information was collected on the basis of
self‐report during the in‐home interviews. Race/ethnicity was cate-
gorized as non‐Hispanic white, non‐Hispanic black, Mexican
American, and other. However, we did not present estimates for
individuals in the “other” race category given the heterogeneity of
this group. Other variables included age (years), sex (male and
female), and highest level of education (<high school and ≥high
school).2.4 | Statistical analysis
Appropriate sampling weights for the fasting subsample were
incorporated to produce national population estimates and to
account for unequal probabilities of selection, nonresponse, and non-
coverage. All analyses were conducted using Stata software, version
12.1 (Stata Corp, College Station, Texas). The SVY module was used
in all analyses with Taylor series linearization methods to adjust for
the complex survey design. Descriptive estimates were age standard-
ized by the direct method to the year 2000 US Census population
using the age groups 20 to 34 years, 35 to 64 years, and 65 to
74 years. Differences in estimates across the 2 survey periods
(1988‐1994 and 2007‐2012) were evaluated using the t statistic,
and a P value of <.05 was considered statistically significant. We
used linear probability models to separately estimate prevalence
differences (PDs) in diabetes and prediabetes over time. Because
associations of BMI with diabetes and prediabetes were not linear
across the BMI distribution, in exploratory analyses, we first used a
nonparametric approach to model the BMI‐outcome relationship by
relying on narrowly defined BMI categories. Models were further
adjusted for cubic terms for age (due to nonlinear relationship with
the outcomes), sex, race/ethnicity, education, survey period, and
interactions between BMI and survey period. On the basis of the
observed inflection points and to improve efficiency, we
subsequently categorized BMI using the standard cut‐points to
define obesity and reestimated PDs in diabetes and prediabetes over
time in adjusted models. We also evaluated heterogeneity by race/
ethnicity by including the relevant interaction terms. To investigate
whether PDs in diabetes and prediabetes over time were
attenuated after accounting for the higher mean WC over time
within the BMI categories, we subsequently added WC as a
continuous variable to the models using a quadratic specification
since it improved the model fit. In sensitivity analyses, we substituted
WC with a continuous measure of BMI to evaluate whether
increases in diabetes and prediabetes over time were merely a
function of a higher mean BMI within the BMI categories. Finally,
some studies have shown that there is more power to predict
cardiovascular risk outcomes when using a composite measure that
combines BMI and WC, over using the 2 measures independently.17
Thus, we also evaluated whether a composite measure of BMI and
WC (created by classifying individuals into mutually exclusive BMI
and WC category combinations using established cutoffs for BMI
and WC18) identified diabetes and prediabetes in 2007‐2012 as well
as in 1988‐1994.3 | RESULTS
Table 1 presents age‐standardized mean BMI and mean WC by BMI
categories across survey periods for participants in the analytic sample
and by race/ethnicity. In general, mean BMI, but to a much greater
extent, mean WC, increased over time within BMI categories. How-
ever, the magnitude of WC increase was largest among individuals
with class II/III obesity. For the most part, these patterns held across
race/ethnic groups; though within most BMI categories, mean WC
was similar or lower among blacks and Mexican Americans than among
whites. Age‐standardized glycemic characteristics are presented in
Table 2. Prevalence of normoglycemia declined considerably over time
in the United States, in conjunction with an increase in dysglycemia
that was driven largely by a rise in prediabetes prevalence over time.
However, this large increase in prediabetes appeared to occur to the
greatest extent among whites, resulting in much smaller race/ethnic
disparities in prediabetes by 2007‐2012. Nevertheless, blacks and
Mexican Americans experienced increases in diabetes prevalence
twice as large as that for whites, resulting in a widening of diabetes dis-
parities over time.
Figure 1A and 1B depicts diabetes and prediabetes prevalence
over time, respectively, across narrowly defined categories of BMI.
All estimates are based on multivariate linear probability models
adjusting for age, sex, race/ethnicity, education, survey year, BMI,
and BMI*survey year (P‐interaction = .0067). Across normal, over-
weight, and class I obese values, there were no statistically significant
differences in diabetes prevalence over time (Figure 1A). However,
among individuals with a BMI roughly greater than 36 kg/m2, diabetes
prevalence was significantly higher over time. For prediabetes,
although the BMI*survey year interaction did not reach statistical
significance (P = .06), estimates suggested that across the distribution
of BMI values in the normal, overweight, and class I obesity range,
but not in the class II/III obese range, prediabetes prevalence wassignificantly higher in 2007‐2012 than in 1988‐1994 (Figure 1B). Pat-
terns were qualitatively similar for men and women though estimates
for diabetes were larger for men (not shown).
In Table 3, we show PDs in diabetes (top panel) and prediabetes
(bottom panel) across the 2 survey periods by BMI estimated from
linear probability models. To improve efficiency, BMI was
introduced into the models as a categorical variable using the
broader, standard cutoffs. Model 1 included adjustment for the same
sociodemographic covariates as in Figure 1A and 1B. Consistent
with the pattern observed in Figure 1A, among class II/III obese
adults, diabetes prevalence was 7.6 percentage points higher in
2007‐2012 than in 1988‐1994, whereas for normal, overweight,
and class I obese adults, there was little difference in diabetes prev-
alence over time. Adding WC to the model resulted in a partial
attenuation of the PD across all BMI categories, including the class
II/III obese, though the PD for this group remained large (PD = 5.4%,
95% CI, −0.18 to 11.0) (model 2). Replacing WC with a continuous
measure of BMI in model 3 did not result in a similar degree of
attenuation (not shown). Findings for prediabetes were similar to
the patterns observed in Figure 1B. Adjusting for WC resulted in
only a slight attenuation of the PDs, which nevertheless remained
large and statistically significant (lower panel, model 2). Even though
research has shown that a composite measure of BMI and WC does
a better job of identifying risk than either measure independently,17
we nevertheless observed the same deterioration in predictive
power over time. Even with a cross‐categorized composite measure
of BMI and WC, we still observed residual time trends for diabetes
and prediabetes similar to the ones from our main analyses
(Table S1). There was no evidence that the secular trends in diabetes
and prediabetes by BMI differed for any of the race/ethnic groups
(all P‐interaction > .3). However, estimates suggested that the PD
in diabetes over time among individuals with class II/III obesity
was largest for Mexican Americans (PD = 8.4%, 95% CI, 0.8‐15.9)
and smallest for blacks (PD = 6.6, 95% CI, −1.4 to 14.6) (Table S2,
top panel, model 1). Inclusion of WC partially attenuated diabetes
PD estimates for all race/ethnic groups (model 2). Using the same
model, it was also evident that disparities in diabetes prevalence
among blacks and Mexican Americans relative to whites were pres-
ent across all BMI categories, remained in both periods, and
persisted even after adjustment for WC (Figure 2).4 | DISCUSSION
Obesity as defined by BMI is a major contributor to glucose dys-
regulation. However, given studies that have shown increased cen-
tral adiposity for the same BMI in more recent years, we
investigated the implications of this trend on diabetes and predia-
betes prevalence over time. Among individuals with class II/III obe-
sity—the group that experienced the largest temporal increases in
mean WC—diabetes prevalence in 2007‐2012 was higher than in
1988‐1994. Adjustment for WC partially attenuated this estimate.
While diabetes prevalence did not increase across the BMI groups
at the lower end of the distribution, prediabetes prevalence did rise



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































d.mean WC. These secular trends were observed within all race/eth-
nic groups.
A few studies have examined trends across a broad range of car-
diovascular disease risk factors by BMI.19,20 The most recent of these
also noted that among individuals with class II/III obesity
(BMI ≥ 35 kg/m2), prevalence of not only diabetes but also
hypertension and dyslipidemia increased between 1999‐2002 and
2007‐2010.19 Another study that evaluated trends over a much
earlier timeframe (1976‐1980 through 1999‐2000) did not find
evidence of a significant change in diabetes prevalence by BMI
category,21 suggesting that these adverse trends reflect a more recent
phenomenon. However, these studies did not consider the role of WC
in potentially accounting for these observed patterns nor was there
consideration of potential race/ethnic differences.
A higher mean WC over time among individuals with class II/III
obesity may be at least part of the reason why diabetes prevalence
increased over time in this group in the US overall and within race/
ethnic groups. Adjustment for a continuous measure of BMI instead
of WC did not have the same impact on estimates, suggesting that
a change in fat distribution may be playing a role. While our study
did not address the causes underlying this potential shift in body
composition, others have speculated that factors such as higher
sedentary activity, diets high in sugar and refined carbohydrates,
sleep deprivation, and some pharmaceuticals may underlie greater
accumulation of abdominal fat for a given BMI.22 Similar factors
have also been implicated in BMI‐independent pathways to
diabetes.23–25 Individuals with BMI extremes constitute an
increasing proportion of the US population, and such BMI extremes
are especially prevalent among minorities.1,26 As a result, these
trends present a cause for concern because of the potential to
further exacerbate race/ethnic disparities in diabetes and related
outcomes.
Although mean WC also increased over time within BMI
groups <35 kg/m2, there were no secular changes in diabetes
prevalence. However, prediabetes prevalence increased dramatically
for individuals in this BMI range. This is consistent with another
study that documented an overall 21% increase in prediabetes in
the United States from 1999 to 2010, despite adjustment for
BMI, and an especially concerning trend among individuals with
normal BMI.9 In our study, we explored whether greater central
fat for same BMI might explain these patterns but noted only a
very mild attenuation of estimates after adjustment for WC.
Reasons behind this dramatic increase in prediabetes remain
unclear, though similar to diabetes, lifestyle and environmental
factors may be contributing to BMI‐independent pathways.
Importantly, this concerning trend of increasing glucose dysregula-
tion particularly among individuals with lower BMI values points
to the potential for underestimation of metabolic consequences if
relying on anthropometric measures alone for risk prediction.
Prediabetes is associated with an increased risk of developing
diabetes and a higher prevalence cardiovascular risk factor
clustering.27 Thus, additional research will be necessary to identify
the modifiable factors underlying this rise in prediabetes.
The overall trends in diabetes and prediabetes by BMI extended to
all race/ethnic groups. Nevertheless, diabetes disparities among blacks
FIGURE 1 Adjusted prevalence of diabetes
(A) and prediabetes (B) by BMI over time
among US adults aged 20 to 74 years. Linear
probability model further adjusted for age,
age2, age3, sex, race/ethnicity, and education.
BMI, body mass indexand Mexican Americans compared to whites within BMI categories
were large and present across the 20+year timeframe. Moreover,
because Mexican Americans in the class II/III obese category
experienced a slightly greater increase in diabetes prevalence over
time than corresponding whites, the potential exists for disparities
to worsen over time. Other studies have noted similar race/ethnic
disparities in diabetes that persist even among individuals with
normal BMI.10,11 However, the inclusion of WC in our models did
not attenuate race/ethnic differences. On the contrary, our descrip-
tive analyses showed that mean WC within BMI categories among
blacks and Mexican Americans was often similar or lower than
among whites. Why blacks and Mexican Americans have more
diabetes even at the lower end of the BMI distribution, and even
after adjusting for WC, is unknown. Hypotheses related to
differences in body composition, diets high in sugar, low levels of
physical activity, genetic predisposition, and differential insulin
sensitivity and beta cell function by degree and location of bodyfat have been posited, but a definitive explanation remains
elusive.28–30 Given the fast growth of minorities, and especially of
Mexican Americans,31 identifying the reasons underlying this dispar-
ity will be essential to stem the diabetes epidemic in the US overall
and in these high‐risk populations.
Although the diagnostic criteria for diabetes and prediabetes
have changed over time, we relied on a combination of self‐reported
status (for diabetes) as well as measured FPG and HbA1c to define
our outcomes. Therefore, improved screening and detection was
not a key driver of our findings given the consistency of our defini-
tions across the study timeframe. However, one limitation was that
we did not differentiate diabetes by type since NHANES does make
this distinction. While type 1 diabetes is on the rise in the United
States,32 the proportion of the adult population with type 1 is likely
to be too small to meaningfully alter our findings. Waist
circumference is also a relatively crude indicator of central adiposity
and is measured with error, especially in individuals with class II/III
TABLE 3 Multivariate adjusted prevalence difference of diabetes and prediabetes by BMI and NHANES survey period for US adults aged 20 to
74 years




1988‐1994 Ref Ref Ref Ref
2007‐2012 0.03 (−1.5, 1.5) 1.1 (−0.7, 2.8) 1.5 (−2.3, 5.4) 7.6 (1.7, 14.4)
Model 2
Survey period
1988‐1994 Ref Ref Ref Ref




1988‐1994 Ref Ref Ref Ref
2007‐2012 12.6 (9.0, 16.1) 11.2 (7.2, 15.3) 10.8 (4.5, 17.2) 3.0 (−5.4, 11.4)
Model 2
Survey period
1988‐1994 Ref Ref Ref Ref
2007‐2012 11.2 (7.6, 14.8) 10.5 (6.4, 14.5) 10.4 (4.0, 16.7) 3.0 (−5.5, 11.6)
Abbreviations: BMI, body mass index; NHANES, National Health and Nutrition Examination Survey.
Data are prevalence differences and 95% CI obtained from linear probability models.
Model 1 includes age, age2, age3, sex, race/ethnicity, education, BMI categories, survey period, and BMI categories*survey period.
Model 2: Model 1 + waist circumference (quadratic term).
FIGURE 2 Adjusted prevalence of diabetes
by race/ethnicity within BMI categories across
NHANES survey periods: 1988‐1994 to
2007‐2012, US adults aged 20 to 74 years.
Prevalence estimates obtained from a linear
probability model further adjusted for age,
age2, age3, sex, education, and waist
circumference. *P < .05, comparing each race/
ethnic group to non‐Hispanic white referent
within BMI categories and within survey
period. BMI, body mass index; NHANES,
National Health and Nutrition Examination
Surveysobesity. However, we do not expect this to impact our findings since
this error would need to be differential over time to bias our
findings. Finally, this analysis relied on cross‐sectional data with only
1‐time measurements of FPG and HbA1c and BMI and WC.
Intraindividual variability may have led to misclassification of diabe-
tes and prediabetes and mismeasurement of adiposity in someinstances. Furthermore, because of the cross‐sectional design, we
were unable to eliminate residual confounding and the potential role
of other unmeasured factors that may have contributed to the pat-
terns we report. Nevertheless, the goal of this study was to charac-
terize how diabetes and prediabetes prevalence by BMI changed
over time and to evaluate how estimates were impacted after
accounting for secular increases in mean WC. Additional research
will be necessary to determine the causal mechanisms underlying
the patterns we report.
In summary, we showed that diabetes prevalence increased over
time among individuals with class II/III obesity with some attenua-
tion after adjustment for WC. Although all race/ethnic groups were
affected, the somewhat steeper increases among Mexican Americans
have the potential to worsen race/ethnic disparities especially given
the already high rates of obesity among Mexican Americans. This
pattern was compounded by the fact that diabetes prevalence was
higher for both blacks and Mexican Americans relative to whites,
even at the lower end of the BMI distribution. Finally, we also doc-
umented a dramatic increase in prediabetes over time across all
race/ethnic groups, which was especially apparent among normal
weight individuals and which persisted even with adjustment for
WC. Although obesity has been considered one of the primary
contributors to the current epidemic of diabetes in the United
States, it will be important to more carefully consider the role of
other risk factors given the prediabetes prevalence among the
normal weight and given the greater diabetes prevalence among
minorities irrespective of anthropometry.
ACKNOWLEDGEMENTS
This research received support from the Population Research
Infrastructure Program (R24 HD050924) awarded to the Carolina
Population Center at the University of North Carolina at Chapel Hill
by the Eunice Kennedy Shriver National Institute of Child Health and
Human Development.
Findings from this work were previously presented at the Obesity
Society's 32nd Annual Scientific Meeting.CONFLICTS OF INTERESTS
None declared.
REFERENCES
1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and
trends in the distribution of body mass index among US adults,
1999‐2010. JAMA. 2012;307(5):491‐497.
2. Walls HL, Stevenson CE, Mannan HR, et al. Comparing trends in BMI
and waist circumference. Obesity (Silver Spring). 2011;19(1):216‐219.
3. Albrecht SS, Barquera S, Popkin BM. Exploring secular changes in the
association between BMI and waist circumference in Mexican‐origin
and white women: a comparison of Mexico and the United States. Am
J Hum Biol. 2014;26(5):627‐634.
4. Elobeid MA, Desmond RA, Thomas O, Keith SW, Allison DB. Waist cir-
cumference values are increasing beyond those expected from BMI
increases. Obesity (Silver Spring). 2007;15(10):2380‐2383.
5. Ford ES, Maynard LM, Li C. Trends in mean waist circumference and
abdominal obesity among US adults, 1999‐2012. JAMA. 2014;
312(11):1151‐1153.
6. Albrecht SS, Gordon‐Larsen P, Stern D, Popkin BM. Is waist circumfer-
ence per body mass index rising differentially across the United States,
England, China and Mexico? Eur J Clin Nutr. 2015 May 6. doi: 10.1038/
ejcn.2015.717. Cheng YJ, Imperatore G, Geiss LS, et al. Secular changes in the age‐
specific prevalence of diabetes among U.S. adults: 1988‐2010. Diabetes
Care. 2013;36(9):2690‐2696.
8. Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations
between trends in race/ethnicity, aging, and body mass index with dia-
betes prevalence in the United States: a series of cross‐sectional
studies. Ann Int Med. 2014;161(5):328‐335.
9. Bullard KM, Saydah SH, Imperatore G, et al. Secular changes in U.S. pre-
diabetes prevalence defined by hemoglobin A1c and fasting plasma
glucose: National Health and Nutrition Examination Surveys,
1999‐2010. Diabetes Care. 2013;36(8):2286‐2293.
10. Zhang Q, Wang Y, Huang ES. Changes in racial/ethnic disparities in the
prevalence of type 2 diabetes by obesity level among US adults. Ethn
Health. 2009;14(5):439‐457.
11. Marcinkevage JA, Alverson CJ, Narayan KM, Kahn HS, Ruben J, Correa
A. Race/ethnicity disparities in dysglycemia among U.S. women of
childbearing age found mainly in the nonoverweight/nonobese. Diabe-
tes Care. 2013;36(10):3033‐3039.
12. Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for
diagnosed diabetes among adults aged 20 to 79 years, United States,
1980‐2012. JAMA. 2014;312(12):1218‐1226.
13. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, ThompsonTJ.
Trends in lifetime risk and years of life lost due to diabetes in the USA,
1985‐2011: a modelling study. Lancet Diabetes Endocrinol. 2014
Nov;2(11):867‐874.
14. Centers for Disease Control and Prevention (CDC). National Health
and Nutrition Examination Survey. Website: http://www.cdc.gov/
nchs/nhanes.htm. (accessed January 7, 2014).
15. American Diabetes Association. Executive summary: standards of
medical care in diabetes‐‐2014. Diabetes Care. 2014;37(Suppl 1):
S5‐13.
16. Steffes M, Cleary P, Goldstein D, et al. Hemoglobin A1c measure-
ments over nearly two decades: sustaining comparable values
throughout the diabetes control and complications trial and the epi-
demiology of diabetes interventions and complications study. Clin
Chem. 2005;51(4):753‐758.
17. Zhu S, Heshka S, Wang Z, et al. Combination of BMI and waist circum-
ference for identifying cardiovascular risk factors in whites. Obes Res.
2004;12(4):633‐645.
18. World Health Organization. Obesity: Preventing and Managing the
Global Epidemic.Report of a WHO consultation on obesity. Geneva:
World Health Organization; 2000.
19. Saydah S, Bullard KM, Cheng Y, et al. Trends in cardiovascular disease
risk factors by obesity level in adults in the United States, NHANES
1999‐2010. Obesity (Silver Spring). 2014;22(8):1888‐1895.
20. Gregg EW, Cheng YJ, Bl C, et al. Secular trends in cardiovascular dis-
ease risk factors according to body mass index in US adults. JAMA.
2005;293(15):1868‐1874.
21. Gregg EW, Bl C, Cheng YJ, et al. Trends in the prevalence and ratio of
diagnosed to undiagnosed diabetes according to obesity levels in the
U.S. Diabetes Care. 2004;27(43):2806‐2812.
22. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an
update. Physiol Rev. 2013;93(1):359‐404.
23. Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming
beverages sweetened with fructose, glucose, sucrose, or high‐fructose
corn syrup. Am J Clin Nutr. 2008;88(6):1733S‐1737S.
24. Gill JM, Cooper AR. Physical activity and prevention of type 2 diabetes
mellitus. Sports Med. 2008;38(10):807‐824.
25. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental
chemicals in diabetes and obesity: a National Toxicology Program
workshop review. Environ Health Perspect. 2012;120(6):779‐789.
26. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the
United States. Int J Obes (Lond). 2013;37(6):889‐891.
27. American Diabetes Association. Standards of medical care in diabetes‐‐
2014. Diabetes Care. 2014;37(Suppl 1):S14‐S80.
28. Goran MI, Bergman RN, Cruz ML, Watanabe R. Insulin resistance and
associated compensatory responses in African‐American and Hispanic
children. Diabetes Care. 2002;25(12):2184‐2190.
29. Chiu KC, Cohan P, Lee NP, Chuang LM. Insulin sensitivity differs among
ethnic groups with a compensatory response in beta‐cell function.
Diabetes Care. 2000;23(9):1353‐1358.
30. Dagogo‐Jack S. Ethnic disparities in type 2 diabetes: pathophysiology
and implications for prevention and management. J Natl Med Assoc.
2003;95(9):774 9‐89
31. TheMexican‐Americanboom:Birthsovertake immigration.Washington,
D.C.: PewHispanic Center 2011.
32. Dabelea D, Mayer‐Davis EJ, Saydah S, et al. Prevalence of type 1 and
type 2 diabetes among children and adolescents from 2001 to 2009.
JAMA. 2014;311(17):1778‐1786.SUPPORTING INFORMATION
Additional Supporting Information may be found online in the
supporting information tab for this article.
